{
  "first_published_at": "2013-04-24", 
  "original_url": "http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/CON266137", 
  "title": "Recent drug-name confusion: please be vigilant as life-threatening errors may occur", 
  "tags": "{\"parsed_therapeutic\": [\"dentistry\"], \"Audience:\": [\"Primary care\", \"Secondary care\", \"Dentists\"]}", 
  "_document_number": 76, 
  "label": "Reminder", 
  "icon": "http://www.mhra.gov.uk/home/images/MHRALook/img/dsu/dose_icon.png", 
  "therapeutic_area": [
    "dentistry"
  ], 
  "raw_html": "<div id=\"dsuArticleContent\">\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\t<h1><a name=\"maincontent\" id=\"maincontent\"></a>Recent drug-name confusion: please be vigilant as life-threatening errors may occur</h1>\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<span class=\"ref\">Article date: April 2013</span> \r\n\t\t\t\t\t\t\t\t<!--SS_BEGIN_ELEMENT(region1_element21)-->\r\n\t\t\t\t\t\t\t\t<!--We would like to remind healthcare professionals to remain vigilant with regard to drug names because serious errors have occurred when medicines with similar names have been confused-->\r\n\t\t\t\t\t\t\t\t<!--SS_END_ELEMENT(region1_element21)-->\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<!--SS_BEGIN_ELEMENT(region1_element22)-->\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<!--SS_END_ELEMENT(region1_element22)-->\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<!--SS_BEGIN_ELEMENT(region1_element13)-->\r\n\t\t\t\t\t\t\t\t<!--<p>We have recently been made aware of medication errors resulting from patients being prescribed or supplied with the wrong medicine from the list below, due to confusion between similarly named products.</p>\n\n<p>Take particular care when prescribing or dispensing these medicines because their names could be confused with each other (ie, they sound alike or look alike).</p>\n\n<p>Recent examples of medicine names that have been confused resulting in medication errors include:</p>\n\n<ul>\n<li>Mercaptamine and mercaptopurine</li>\n\n<li>Sulfadiazine and sulfasalazine</li>\n\n<li>Risperidone and ropinirole</li>\n\n<li>Zuclopenthixol decanoate and zuclopenthixol acetate<br />\n</li>\n</ul>\n\n<p>Some of these errors could result in life-threatening conditions. We previously issued a reminder to remain vigilant when prescribing mercaptamine or mercaptopurine after a case of a 9-month-old who was erroneously prescribed mercaptopurine instead of mercaptamine by their GP. After approximately 1 month of incorrect treatment, the child was admitted to hospital with pancytopenia; the child fortunately made a full recovery (see <a target=\"_blank\" href=\"http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/CON096800\">Drug Safety Update, October 2010</a>).&#160;</p>\n\n<div class=\"dull_highlight\">\n<p>Remember that the medicines listed above are used to treat different conditions or patients:</p>\n\n<p><strong>Mercaptamine</strong> is indicated for the treatment of proven nephropathic cystinosis<br />\n<strong>Mercaptopurine</strong> is indicated for the treatment of acute leukaemia</p>\n\n<p><strong>Sulfadiazine</strong> is indicated for the prevention of rheumatic fever<br />\n<strong>Sulfasalazine</strong> is used in the treatment of: mild to moderate and severe ulcerative colitis and maintenance of remission; active Crohn&#8217;s disease; and rheumatoid arthritis</p>\n\n<p><strong>Risperidone</strong> is used in schizophrenia and other psychoses<br />\n<strong>Ropinirole</strong> is used in Parkinsonism and related disorders</p>\n\n<p><strong>Zuclopenthixol acetate</strong> is used in schizophrenia and other psychoses<br />\n<strong>Zuclopenthixol decanoate</strong> is used in long-acting formulations for patients with schizophrenia in whom oral maintenance therapy is unreliable</p>\n</div>\n\n<p>If pharmacists have any doubt about which of these medicines is intended they should contact the prescriber before dispensing the drug. Health professionals should remain vigilant when dealing with these medicine names, which either look alike when written or sound alike. In addition, ensure that the correct medicine name is chosen from any drop-down lists in a prescribing database.</p>\n\n<p>Please report any suspected adverse drug reactions, including those arising from medication errors, to the MHRA through the <a target=\"_blank\" href=\"http://www.mhra.gov.uk/yellowcard\">Yellow Card Scheme</a>.</p>\n\n<p><em>Article citation: Drug Safety Update April 2013, vol 6, issue 9: H1.</em></p>-->\r\n\t\t\t\t\t\t\t\t<!--SS_END_ELEMENT(region1_element13)-->\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<!-- SS_BEGIN_SNIPPET(fragment7,1)-->\r\n\t\t\t\t\t\t\t\t<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t<p>We have recently been made aware of medication errors resulting from patients being prescribed or supplied with the wrong medicine from the list below, due to confusion between similarly named products.</p>\n\n<p>Take particular care when prescribing or dispensing these medicines because their names could be confused with each other (ie, they sound alike or look alike).</p>\n\n<p>Recent examples of medicine names that have been confused resulting in medication errors include:</p>\n\n<ul>\n<li>Mercaptamine and mercaptopurine</li>\n\n<li>Sulfadiazine and sulfasalazine</li>\n\n<li>Risperidone and ropinirole</li>\n\n<li>Zuclopenthixol decanoate and zuclopenthixol acetate<br>\n</li>\n</ul>\n\n<p>Some of these errors could result in life-threatening conditions. We previously issued a reminder to remain vigilant when prescribing mercaptamine or mercaptopurine after a case of a 9-month-old who was erroneously prescribed mercaptopurine instead of mercaptamine by their GP. After approximately 1 month of incorrect treatment, the child was admitted to hospital with pancytopenia; the child fortunately made a full recovery (see <a target=\"_blank\" href=\"http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/CON096800\">Drug Safety Update, October 2010</a>).&#160;</p>\n\n<div class=\"dull_highlight\">\n<p>Remember that the medicines listed above are used to treat different conditions or patients:</p>\n\n<p><strong>Mercaptamine</strong> is indicated for the treatment of proven nephropathic cystinosis<br>\n<strong>Mercaptopurine</strong> is indicated for the treatment of acute leukaemia</p>\n\n<p><strong>Sulfadiazine</strong> is indicated for the prevention of rheumatic fever<br>\n<strong>Sulfasalazine</strong> is used in the treatment of: mild to moderate and severe ulcerative colitis and maintenance of remission; active Crohn&#8217;s disease; and rheumatoid arthritis</p>\n\n<p><strong>Risperidone</strong> is used in schizophrenia and other psychoses<br>\n<strong>Ropinirole</strong> is used in Parkinsonism and related disorders</p>\n\n<p><strong>Zuclopenthixol acetate</strong> is used in schizophrenia and other psychoses<br>\n<strong>Zuclopenthixol decanoate</strong> is used in long-acting formulations for patients with schizophrenia in whom oral maintenance therapy is unreliable</p>\n</div>\n\n<p>If pharmacists have any doubt about which of these medicines is intended they should contact the prescriber before dispensing the drug. Health professionals should remain vigilant when dealing with these medicine names, which either look alike when written or sound alike. In addition, ensure that the correct medicine name is chosen from any drop-down lists in a prescribing database.</p>\n\n<p>Please report any suspected adverse drug reactions, including those arising from medication errors, to the MHRA through the <a target=\"_blank\" href=\"http://www.mhra.gov.uk/yellowcard\">Yellow Card Scheme</a>.</p>\n\n<p><em>Article citation: Drug Safety Update April 2013, vol 6, issue 9: H1.</em></p>\r\n\t\t\t\r\n\t\t\t\t\t\t\t\t<!-- SS_END_SNIPPET(fragment7,1)-->\r\n\t\t\t\t\t\t\t</div>\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t", 
  "date_of_article": "2013-04-01", 
  "date_last_modified": "2013-04-29", 
  "_assets": [], 
  "_item_id": 76, 
  "summary": "", 
  "body": "Article date: April 2013\n\nWe have recently been made aware of medication errors resulting from patients being prescribed or supplied with the wrong medicine from the list below, due to confusion between similarly named products.\n\nTake particular care when prescribing or dispensing these medicines because their names could be confused with each other (ie, they sound alike or look alike).\n\nRecent examples of medicine names that have been confused resulting in medication errors include:  \n  \n  * Mercaptamine and mercaptopurine  \n  * Sulfadiazine and sulfasalazine  \n  * Risperidone and ropinirole  \n  * Zuclopenthixol decanoate and zuclopenthixol acetate  \n  \n  \nSome of these errors could result in life-threatening conditions. We previously issued a reminder to remain vigilant when prescribing mercaptamine or mercaptopurine after a case of a 9-month-old who was erroneously prescribed mercaptopurine instead of mercaptamine by their GP. After approximately 1 month of incorrect treatment, the child was admitted to hospital with pancytopenia; the child fortunately made a full recovery (see [Drug Safety Update, October 2010](http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/CON096800)). \n\nRemember that the medicines listed above are used to treat different conditions or patients:\n\nMercaptamine is indicated for the treatment of proven nephropathic cystinosis  \nMercaptopurine is indicated for the treatment of acute leukaemia\n\nSulfadiazine is indicated for the prevention of rheumatic fever  \nSulfasalazine is used in the treatment of: mild to moderate and severe ulcerative colitis and maintenance of remission; active Crohn’s disease; and rheumatoid arthritis\n\nRisperidone is used in schizophrenia and other psychoses  \nRopinirole is used in Parkinsonism and related disorders\n\nZuclopenthixol acetate is used in schizophrenia and other psychoses  \nZuclopenthixol decanoate is used in long-acting formulations for patients with schizophrenia in whom oral maintenance therapy is unreliable\n\nIf pharmacists have any doubt about which of these medicines is intended they should contact the prescriber before dispensing the drug. Health professionals should remain vigilant when dealing with these medicine names, which either look alike when written or sound alike. In addition, ensure that the correct medicine name is chosen from any drop-down lists in a prescribing database.\n\nPlease report any suspected adverse drug reactions, including those arising from medication errors, to the MHRA through the [Yellow Card Scheme](http://www.mhra.gov.uk/yellowcard).\n\nArticle citation: Drug Safety Update April 2013, vol 6, issue 9: H1.\n"
}